12.05.2016 • News

Kullmann appointed Deputy Chairman of the Executive Board of Evonik

The Supervisory Board of Evonik appointed Christian Kullmann (47) Deputy Chairman of the Executive Board with immediate effect. Kullmann has been on the Executive Board since July 2014 and has the role of chief strategic officer. He joined the company in 2003.

Klaus Engel, Chairman of the Executive Board, compliments Kullmann, who could become his designated successor: “I highly recommended Christian Kullmann as a Board Member at the time, and I now recommend him equally highly as my deputy. He stands for continuity and dependability towards employees, customers and investors. We will continue along our successful path in the same spirit of trusting cooperation.”

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

Free Virtual Event

Batteries and Hydrogen: Competitors or Partners?
CHEManager Spotlight

Batteries and Hydrogen: Competitors or Partners?

17 September 2026 | Reserve your spot to learn where solid-state batteries and green hydrogen are headed—and how leading teams are turning them into scalable energy storage solutions.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.